ProPublica: 10 drugs with the highest physician payments from companies

ProPublica updated its Dollars for Docs database that features payments companies made to physicians from August 2013 through December 2015.

Dollars for Docs lists the following 10 drugs for which companies paid the most in payments to physicians last year:

1. Xarelto (a blood thinner) — $28.4 million

2. Humira (rheumatoid arthritis drug)  — $24.9 million

3. Invokana (drug for diabetes)  — $20.9 million

4. Viekira (hepatitis C drug)  — $19.2 million    

5. Eliquis (blood thinner) — $18.8 million

6. Bydureon (diabetes drug) — $18.5 million

7. Androgel (testosterone drug)— $15.3 million

8. Synthroid (thyroid drug)—$14.7 million

9. Lupron (synthetic hormone) — $14.3 million

10. Victoza (diabetes drug)— $11.9 million

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast